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ABSTRACT
Objective: Research shows a signiﬁcant
association between eating disorders (ED)
and substance use disorders (SUD). The
objective of this study is to examine the
prevalence, chronology, and possibility of
shared familial risk between SUD and ED
symptomatology.
Method: Subjects included 1,206
monozygotic and 877 dizygotic adult
female twins. ED symptomatology
included anorexia (AN) and bulimia nerv-
osa (BN) diagnosis, symptoms associated
with diagnostic criteria, and BN symptom
count. SUD included alcohol, illicit drug,
and caffeine abuse/dependence. General-
ized estimated equation modeling was
used to examine phenotypic associations,
and Choleksy decompositions were used
to delineate the contribution of genes
and environment to comorbidity.
Results: There were no signiﬁcant dif-
ferences between SUD prevalence in
women with AN and BN. Women with BN
reported BN preceded SUD development
while the reverse was true for AN. Twin
analyses showed possible familial over-
lap between BN symptomatology and all
SUD examined.
Discussion: Results suggest an impor-
tant difference in the chronology of EDs
and SUDs. Women with BN may be turn-
ing to substances to dampen bulimic
urges. Women with AN may be engaging
in substance use initially in an effort to
lose weight. Results also suggest familial
factors contribute to the comorbidity
between BN and SUD. V V C 2010 by Wiley
Periodicals, Inc.
Keywords: bulimia nervosa; anorexia
nervosa; disordered eating; substance
use disorders; comorbidity; prevalence;
twin study; genetics
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Introduction
Rates of substance use and substance use disorders
(abuse/dependence) are high among women with
eating disorders (ED). This association is greatest
in women with bulimia nervosa (BN) and anorexia
nervosa (AN) binge purge subtype and is exhibited
for both alcohol and illicit drug disorders.
1–5 Find-
ings from the few studies investigating chronology
of EDs and substance use disorders suggest a bidir-
ectional association. Cross-sectional studies reveal
somewhat similar rates of women reporting onset
of a substance use disorder (SUD) to precede an
ED and vice versa.
6,7 Moreover, in a 9-year longitu-
dinal examination, 18% of women with AN and
30% of women with BN were diagnosed with a drug
use disorder for the ﬁrst time over the course of
the study, suggesting that the risk for a drug use
disorder continues over time in women with EDs.
8
Similar ongoing risk has been found for alcohol dis-
orders.
9
In addition to illicit drug and alcohol use disor-
ders, regular nicotine use is also frequent in women
with an ED. A higher proportion of women with BN
are regular smokers compared to controls or to
women with AN.
5,10-12 This association may arise
because of the commonly held belief that nicotine
use can aid in weight loss. Therefore, women’s con-
cerns about body weight and shape, which are par-
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CE ACTIVITYticularly salient for women with an ED, may increase
their risk for cigarette use.
5
It remains unclear why EDs and SUDs frequently
coexist; these associations are complex and likely
have several biological and psychosocial inﬂuences.
For example, when women begin to remit from an
ED, they may substitute substances (i.e., dramatic
increase in alcohol consumption) for the ED symp-
toms (i.e., binge eating) or vice versa. In addition, a
common familial diathesis has been proposed. Sev-
eral family studies show increased rates of SUDs in
relatives of women with BN.
1,2,13 However, several
reports also suggest that these two disorders are
transmitted independently.
3,14–16 In contrast to these
latter family studies, twin studies often show a fami-
lial relationship between EDs and SUDs.
Research has shown evidence for shared genetic
inﬂuences between BN and illicit drug abuse/de-
pendence.
6 Authors reported that 83% of the pheno-
typic correlation between BN and illicit drug abuse/
dependence was accounted for by genetic factors.
However, a report examining the overlap between
BN and alcohol use disorders demonstrated that the
two disorders load on distinct genetic factors.
14
Examining the genetic covariance between speciﬁc
ED symptoms and substance use also reveals com-
mon genetic factors. For example, shared genetic
factors were shown to account for a portion of the
covariance between weight preoccupation and
binge eating and alcohol use in both males and
females.
17 Thus, it may be important to examine
speciﬁc ED symptoms and their relation to SUDs
rather than focusing on speciﬁc diagnostic catego-
ries (AN vs. BN). This is an important consideration
as recent work has emphasized the importance of
examining speciﬁc symptoms of an ED noting that,
‘‘A DSM-IV diagnostic category ... might actually
represent an occasionally co-occurring yet etiologi-
cally diverse mixture of genetically and environmen-
tally inﬂuenced symptoms ...’’ (p. 191).
18
Previous work that has examined associations
between ED symptoms and SUDs has been pheno-
typic in nature and shows that, in general, the more
severe the ED symptoms, the greater the number of
substance classes used.
12,19,20 Independent of diag-
nostic category, speciﬁc phenotypic associations
have been shown between caloric restriction and
amphetamine use and binge eating and tranquilizer
use.
20 Severe bingeing is also consistently associated
with alcohol use,
19,21,22 whereas purging behaviors
have been shown to predict the use of a multitude
of substances including alcohol, cocaine, cigarettes,
stimulants, and amphetamines.
9,19-21,23
This study aimed to extend previous research in
this area in several ways. First, we examined the
phenotypic associations between ED diagnoses (AN
and BN) as well as ED symptoms. It was speciﬁcally
hypothesized that signiﬁcant associations would be
found between binge eating and an alcohol use dis-
order, purging behaviors and an alcohol use disor-
der, illicit drug use disorder, and regular smoking
and between body image and an alcohol use disor-
der due to previous associations found between
these variables.
9,21 Second, we also examined the
chronology of comorbid EDs and SUDs. Finally, fol-
low-up twin analyses were conducted between ED
symptomatology and SUDs to examine for genetic
covariance. We hypothesized that ED symptomatol-
ogy and SUDs would show a moderate amount of
genetic covariance. This report is one of the ﬁrst to
integrate all the above-mentioned aspects into one
report using a population-based sample.
This report also adds to previous research examin-
ing similar types of associations using the Virginia
Adult Twin Study of Psychiatric and substance use
disorders in several ways. First, while the association
between BN and illicit drug and alcohol disorders has
been examined within this sample, our previous
reports have only examined associations at the diag-
nostic level and have not examined relations between
BN (at the diagnostic or symptom-level) and smoking
or caffeine disorders. Second, our previous reports
have neglected to include AN. Third, we examine ED
diagnoses in two distinct ways (absence or presence
of diagnosis and symptom count). Last, we include a
detailed examination of the prevalence of comorbid
ED symptomatology and SUDs including an exami-
nation of self-reported chronology of symptoms.
Method
Participants
Participants are from the Virginia Adult Twin Study of
Psychiatric and Substance Use Disorders (VATSPSUD
24).
This is a population-based longitudinal study of adult
Caucasian twins sampled from the Virginia Twin Registry
(VTR, now part of the Mid-Atlantic Twin Registry).
Female–female twin pairs who were born between 1934
and 1968 were targeted for the VATSPSUD. This study
includes 1,206 monozygotic or identical twins (MZ) and
877 dizygotic or fraternal (DZ) female twins. Zygosity was
determined by a computer algorithm of standard ques-
tionnaire responses. This method was validated by DNA
testing and found to be[95% accurate.
25
Measures
Lifetime psychiatric and substance abuse history was
assessed with an adapted version of the Structured Clini-
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26). Information was
drawn from interview Waves 1, 3, and 4. Participation
rates at each wave were 92%, 87.8% and 84.5%, respec-
tively.
Lifetime SUDs
Lifetime SUDs, assessed at Wave 4 interviews, included
alcohol, caffeine, cannabis, sedative, stimulant, cocaine,
opiate, and hallucinogen abuse/dependence. A com-
bined variable of abuse/dependence diagnoses was
created for each of the aforementioned substances.
Similarly, a variable was created to indicate whether the
participant has a lifetime history of any illicit drug use
disorder (including cannabis, sedative, stimulant, co-
caine, opiate, and hallucinogen abuse/dependence). This
was done to decrease the number of possible analyses
and to increase power due to the low prevalence of illicit
drug use disorders. A regular smoking variable was also
included, which indicates whether the participant ever
engaged in an average of at least seven episodes of smok-
ing per month.
Eating Disorders and Symptoms
Eating disorder (ED) symptoms were examined with
the interview questions used to assess AN and BN diag-
noses. Not all participants interviewed were asked the ED
symptomatology questions due to use of ‘‘entry’’ ques-
tions. If participants did not endorse the entry questions,
then all subsequent ED questions were skipped. The
entry question to the BN section asked: ‘‘have you ever in
your life had eating binges during which you ate a lot of
food in a short period of time?’’ Thirty-seven percent
(n 5 718) of women responded yes to the entry question
and endorsed a history of binge eating. The AN entry
question asked: ‘‘have you ever had a time in your life
where you weighed much less than other people thought
you ought to weigh?’’ Thirty-six percent (n 5 780) of
women endorsed the AN entry question.
Bulimia Nervosa
Lifetime history of bulimia nervosa (BN) was assessed
at both Waves 1 and 3 interviews, and a broadly deﬁned
deﬁnition was used. Speciﬁcally, the DSM-III-R ‘‘D’’ crite-
rion that bingeing and purging must occur for twice a
week for 3 months was omitted, and a broader deﬁnition
for concern about body weight and shape was used. This
ranged from ‘‘more concerned than others about body
weight and shape’’ to ‘‘a little bit more concerned about
body weight and shape than others.’’ This broad deﬁni-
tion of BN has been used previously
6,27 and has been
shown to be reliable.
28 Participants were classiﬁed as
having a history of BN if they qualiﬁed for a diagnosis at
interview Waves 1 or 3. Our rationale was that discrepan-
cies are more likely to be due to true change (develop-
ment of problems between waves) or false negatives
(underreporting at one interview) than to false positives
(overreporting at one interview).
We also created a BN symptom count variable, which
included the following symptoms: binge eating (assessed
by the entry question), purging, which could include self-
induced vomiting, laxatives, water pills, exercise, fasting,
or strict dieting (a positive score was given for each purg-
ing behavior identiﬁed), feelings of loss of control during
the binge, amount of food eaten during the binge,
concern about weight, and shape (i.e., body image dis-
turbance), and whether episodes of binge eating and vom-
iting (as the purging behavior) occurred at the same time.
Symptom count information was obtained from Wave 3
interviews only due to slight differences between Waves 1
and 3 questions. For example, Wave 3 questions have
more response/frequency options for the questions and
include questions Wave 1 does not (i.e., amount eaten
during the binge). Information from all participants was
included in the symptom count variable, such that indi-
viduals not endorsing the entry item were coded as zero.
All variables were binary (yes/no) except for loss of
control during the binge, amount eaten during the binge,
and concern about weight and shape. For loss of control
options included: not at all out of control (0), a little out
of control (1), somewhat out of control (2), and com-
pletely out of control (3). Amount eaten during the binge
included a small amount other’s would not regard as un-
usual (0), a large amount others would regard as unusual
(1), and a very large amount others would deﬁnitely
regard as unusual (2). Concern about weight and shape
included same level of concern as others (0), a little bit
more concerned than others (1), somewhat more con-
cerned than others (2), and a lot more concerned than
most girls of the same age (3). All aforementioned vari-
able responses were added together for each participant
to obtain a BN symptom count, which was used in the
twin analyses. The symptom count variable ranged from
0 to 11 with a mean of 1.27 (sd 5 2.5).
Anorexia Nervosa
Lifetime anorexia nervosa (AN) was obtained from
Wave 1 interviews. Again, a broad deﬁnition was created
due to the low prevalence of AN. Participants were con-
sidered to have a lifetime history of AN if one of the fol-
lowing deﬁnitions were met: (a) strict DSM-III-R criteria
were met; (b) meets DSM-III-R criteria dropping criterion
‘‘D’’ (amenorrhea); and (c) meets DSM-III-R criteria
dropping criterion ‘‘C’’ (feeling fat when emaciated).
These deﬁnitions have been used previously within the
VTR,
29,30 and an etiologic continuity between these deﬁ-
nitions was shown.
29 Because of the low prevalence of
AN in the general population and small number of con-
cordant twin pairs in this sample, AN was not included
within the twin model-ﬁtting analyses.
29 Because of these
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Statistical Procedures
Regression Analyses. Logistic regressions were con-
ducted using generalized estimating equation modeling
(GEE
31) as implemented within the PROC GENMOD pro-
cedure in SAS version 9.2
32 to examine for signiﬁcant
associations between ED symptoms and SUDs. Using
this procedure, the robust standard error is invoked,
which adjusts betas and standard errors for the related-
ness of twins in a pair. Members of the twin pair are iden-
tiﬁed (or clustered) within these models by a ‘‘family
number’’ variable that is shared by both members of the
pair. Broad AN and BN diagnoses were included in the
models as covariates for their respective symptoms to
ensure the symptoms examined have a signiﬁcant rela-
tion independent of diagnosis. A more conservative p-
value of .01 was used to assess signiﬁcance for analyses
because of the large number of analyses conducted.
Twin Analyses. For these analyses, a BN symptom
count variable (now referred to as BNSC) was created
(described earlier), which indicates how many symptoms
of BN the participant responded to Yes. AN was not
included in the twin model-ﬁtting analyses. The symp-
tom count variable was created for several reasons: ﬁrst,
to decrease the number of possible analyses conducted
between ED symptoms and SUDs. This decreases the
number of analyses, because it would be possible to con-
duct these analyses with each ED symptom. Second, this
was done to increase power due to the lower prevalence
of EDs in the general population. Third, researchers have
now begun to highlight the importance of assessing EDs
at the symptom level.
18 Most extant research regarding
genetic and environmental inﬂuences on EDs uses bi-
nary items, and participants are coded as meeting criteria
for a disorder (1) or not (0). However, using a threshold
imposed on a symptom count variable tells us nothing
about (i) disorder liability in those who are subthreshold
nor about (ii) severity among those who are above
threshold. There is therefore a loss of information among
both affected and unaffected individuals. To overcome
this problem, we have chosen to use a symptom count
variable to maximize the amount of information and
power in twin-modeling analyses.
Bivariate Cholesky decomposition models were used
to decompose the covariance between BNSC and SUDs
into genetic and environmental components (see Fig. 1).
This model estimates regressions on standardized latent
additive genetic (A), shared environmental (C), and
unique environmental (E; includes measurement error)
variance components. Squared, these regression coefﬁ-
cients provide the amount of genetic (a
2), shared envi-
ronmental (c
2), and unique environmental (e
2) variance
accounted for in a trait. The Cholesky model also yields
estimates of genetic and environmental contributions to
the covariance between traits. These include the genetic
(ra), shared (rc), and unique environmental (re) correla-
tions between the phenotypes. In the present applica-
tion, these are the genetic and environmental correla-
tions between risk factors responsible for ED symptom
count and the speciﬁc SUD examined. For example, an ra
estimated at unity indicates that the same genetic risk
factors contribute to risk for the ED symptom and SUD
under investigation.
The ﬁt of the full ACE model was compared to submo-
dels, including models dropping C (AE model), then A (CE
model), as well as A and C together (E only model). Model
comparisons are conducted by taking the difference in
twice the negative log-likelihood of the models, which,
given certain regularity conditions, is distributed as a chi-
square. A signiﬁcant (p \ .05) change in chi-square indi-
cates that dropping the parameter signiﬁcantly worsens
the ﬁt of the model. Models with fewer parameters are
preferable if they do not result in a signiﬁcantly worse ﬁt.
An alternative comparison method, referred to as Akaike’s
information criterion (AIC
33), was used as well. AIC is cal-
culated as v
2 2 2 df, which indicates the best possible bal-
ance between parsimony and explanatory power. Lower
AIC values indicate better ﬁt. The best-ﬁtting and most
parsimonious model from these analyses was retained.
However, despite the fact we have a fairly large sample
size, both in general and for a twin study, our sample is
not large enough to reject the AE model if the true model
is the CE model
34; therefore, the discussion of the twin
model-ﬁtting results will focus on the full ACE model. The
best-ﬁtting model results will be provided for comparison
to previous VATSPSUD studies.
Results of GEE analyses were used as a guide for twin
analyses. Bivariate analyses were conducted between
BNSC and only those SUDs that showed at least one sig-
FIGURE 1. Bivariate Cholesky decomposition. Notes: ED,
eating disorder symptom; SUD, substance use disorder; A,
additive genetic; C, shared environment; E, unique envi-
ronment; a11, genetic path for ED; c11, shared environ-
mental path for ED; e11, unique environmental path for
ED; a12, genetic covariance between ED and SUD; c12,
shared environmental covariance between ED and SUD;
e12, unique environmental covariance between ED and
SUD; a22, genetic path unique to SUD; c22, shared envi-
ronmental path unique to SUD; e22, unique environmen-
tal path unique to SUD.
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ined in GEE analyses. Analyses were conducted using an
ordinal, raw data approach in the statistical package
Mx,
35 which allows data from both complete and incom-
plete twin pairs to be used.
Results
Demographics
The average ages of participants at interview
W a v e s1 ,3 ,a n d4w e r e3 0 . 0 0( s d5 7.5), 35.12 (sd
5 7.5), and 37.70 (sd 5 7.5), respectively. Fre-
quency of SUDs is shown in Table 1.R e g u l a r
smoking and a caffeine disorder were the most
prevalent substances in the sample. Approxi-
mately 5% of women qualiﬁed for a BN diagnosis
(n 5 118), while 3% (n 5 58) qualiﬁed for AN.
Additionally, we assessed those women in our
sample who qualiﬁed for both AN and BN
(AN1BN). Six women at Wave 1 and fourteen
women at Wave 3 qualiﬁed for AN 1 BN. Examin-
ing age of onset of those women who had a diag-
nosis of AN at Wave 1 and a diagnosis of BN
at Wave 3 (but not Wave 1) shows that a majority
(n 5 6) reported that episodes of binge eating
began 3–16 years after their age of lowest weight.
This suggests to us that these women may have
‘‘progressed’’ from AN to BN as it is typically found
that a majority of women with AN will often later
develop BN after years of starvation. Therefore,
AN 1 BN women were counted in both the AN
category and the BN category.
Average age of onset for AN and BN was also
examined. For AN, we examined the self-reported
age of lowest weight of those individuals who quali-
ﬁed for an AN diagnosis. Mean age of onset for AN
was 18.80 (sd 5 4.8), which is slightly higher than
the age of onset in the general population. This
higher than average age of onset is likely due to
using the participant’s age at lowest weight as age
of onset, and it is probable that onset of AN would
occur well before the participant reached their low-
est weight.
Age of onset for BN was examined at interview
Waves 1 and 3. For Wave 1, the question ‘‘how old
were you when you ﬁrst began to have these symp-
toms’’ was asked at the end of the BN section and
examined in those women who qualiﬁed for BN.
Reported mean age of onset was 18.60 (sd 5 5.3).
Age of onset at Wave 3 was obtained in two ways:
ﬁrst, by inquiring the age at which binge eating
began and, second, by inquiring at what age self-
induced vomiting behaviors began in those women
with BN. Average age of onset of binge eating for
those women with BN was 20.0 (sd 5 7.4), while
the average age of onset of self-induced vomiting
was 21.50 (sd 5 6.4).
Prevalence of Comorbid Eating Pathology
and SUD
ED Diagnoses and SUDs. Frequency of SUDs was
examined in women with AN or BN. Chi-squares
revealed that women with BN were more likely
to have an illicit drug use disorder (1, N 5 1715) 5
12.32, p \ .01, alcohol disorder (1, N 5 1719) 5
20.70, p \ .01, and be regular smokers (1, N 5
1720) 5 5.20, p\.05, compared to those without a
BN diagnosis. Women with AN were more likely to
have an alcohol disorder (1, N 5 1719) 5 6.63, p \
.01 and be regular smokers (1, N 5 1720) 5 6.05,
p \ .01, compared to women without an AN diag-
nosis. The chi-square difference between rates of
an illicit drug use disorder in women with and
without an AN diagnosis approached signiﬁcance
(1, N 5 1715) 5 3.40, p 5 .06.
As can be seen from Table 1, the prevalence of
SUDs in women with AN or BN was quite similar.
TABLE 1. Frequency of substance disorders and of women with anorexia nervosa or bulimia nervosa and a substance
disorder
Prevalence of
substance
disorders
Anorexia nervosa and
comorbid substance
disorder
Bulimia nervosa and
comorbid substance
disorder
% N % N OR (95% CI) % N OR (95% CI)
Any illicit drug disorder
a 8.14 177 17.20 10 2.00 (0.85–4.40) 18.60 22
b 2.39
c (1.40–4.10)
Alcohol 14.00 235 22.40
b 13 2.30
c (1.20–4.50) 24.00 28
b 2.83
c (1.79–4.50)
Caffeine 23.00 382 26.00 15 1.52 (0.78–3.00) 23.00 27 1.40 (1.20–2.23)
Regular smoker 43.00 740 52.00
b 30 2.03 (1.10–3.70) 45.00
d 53 1.60 (1.10–2.50)
Note: %, percentage of women; N, number of women; OR, odds ratio from Generalized Estimating Equation Modeling; CI 95%, conﬁdence interval for
odds ratio.
aAll illicit drug abuse/dependence diagnoses combined into one variable for ease of comparison across eating pathology.
bSigniﬁcant chi-square difference between women positive for AN or BN diagnosis and women scoring zero at p\.01.
cGEE analysis signiﬁcant at p\.01.
dSigniﬁcant chi-square difference between women positive for AN or BN diagnosis and women scoring zero at p\.05.
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disorder and regular smoking, both of which were
more prevalent in women with AN. Twenty-six per-
cent of women with AN had a caffeine disorder,
and 52% were regular smokers compared to 23 and
45% of women with BN, respectively. However, chi-
squares revealed no signiﬁcant differences between
women with AN and BN and any SUD prevalence
rates (p’s [.05).
We also examined the prevalence of the speciﬁc
illicit drug disorders that comprised our ‘‘any illicit
drug disorder’’ variable. Cannabis (13%, n 5 15),
stimulant (9.3%, n 5 11), and cocaine abuse/de-
pendence (9.3%, n 5 11) were the most prevalent
illicit SUDs within BN. Similarly, cannabis (13.8%,
n 5 8), stimulant (13.8%, n 5 8), and cocaine
abuse/dependence (12.1%, n 5 7) were also
the most prevalent illicit SUDs reported in women
with AN.
The chronology of the onset of AN, BN, and SUDs
revealed a bidirectional relationship (Table 2). Only
those women having age of onset information for
both disorders were included. In general, women
with AN reported that their SUD symptoms (positive
report for any symptoms of abuse/dependence) pre-
ceded their symptoms of AN (based on age at lowest
weight in those women with AN), whereas women
with BN reported their symptoms of BN (based on
age binge eating began in those women with BN)
preceded their SUD symptoms. The only exceptions
to this were for BN and regular smoking where more
women reported regular smoking (for at least a
month) to precede binge eating and for AN and an
alcohol use disorder where more women reported
age of lowest weight to occur before the alcohol dis-
order. Age of onsets for an illicit drug use disorder
and a caffeine disorder was determined in a simi-
lar fashion to the previous SUDs mentioned. Age
of onset for an illicit drug use disorder diagnosis
was determined by the minimum possible age for
an abuse/dependence diagnosis for any of the il-
licit drugs, whereas age of onset for a caffeine dis-
order was determined by the age of heaviest caf-
feine use in those women with a caffeine disorder
diagnosis.
ED Symptomatology. The prevalence of SUDs within
women positive for speciﬁc ED symptoms was also
examined, and results are provided in Table 3.I n
general, regular smoking and a caffeine disorder
were again the most prevalent SUDs in women
positive for an ED symptom. All SUDs examined
were most prevalent among women reporting life-
time purging, except for a caffeine disorder, which
was slightly more prevalent in women who are con-
TABLE 2. Chronology of comorbid eating disorder and substance use disorder onset
Substance
disorder
BN 1 SUD BN
precedes
BN 1 SUD SUD
precedes
BN 1 SUD
same age of onset
AN 1 SUD AN
precedes
AN 1 SUD SUD
precedes
AN 1 SUD
Same age of onset
Illicit drug disorder 57% (n 512) 39% (n 5 8) 5% (n 5 1) 33% (n 5 3) 67% (n 5 6) —
Alcohol disorder 70% (n 5 14) 15% (n 5 3) 15% (n 5 3) 67% (n 5 6) 33% (n 5 3) —
Caffeine disorder 70% (n 5 9) 23% (n 5 3) 8% (n 5 1) 50% (n 5 3) 50% (n 5 3) —
Regular smoking 52% (n 5 16) 39% (n 5 12) 10% (n 5 3) 36% (n 5 9) 60% (n 5 15) 4% (n 5 1)
Note: Only those women with age of onset information for both disorders were included. BN 1 SUD, bulimia nervosa and substance use disorder; BN pre-
cedes, bulimia nervosa age of onset precedes substance disorder onset; SUD precedes, substance use disorder age of onset precedes eating disorder onset;
same age of onset, reported age of onset for eating disorder and substance use disorder the same; AN 1 SUD, anorexia nervosa and substance use disorder.
TABLE 3. Frequency of substance disorders within women positive for eating disorder symptomatology
Eating disorder symptom
Illicit drug
disorder
a Alcohol disorder Caffeine disorder Regular smoking
% N OR (95% CI) % N OR (95% CI) % N OR (95% CI) % N OR (95% CI)
Symptoms related to BN
Binge eat 14.20
b 102 2.03
c (1.46–2.83) 17.00
b 121 2.01
c (1.50–2.72) 23.00
b 165 1.63
c (1.26–2.10) 42.80
b 307 1.65
c (1.32–2.08)
Purging behaviors 17.30
b 51 2.61
c (1.63–4.20) 20.10
b 59 2.01
c (1.26–3.32) 22.80 67 1.25 (0.84–1.90) 48.60
b 143 2.46
c (0.70–3.56)
Concern about weight/shape
Symptoms related to AN
14.60
b 60 1.80
c (1.20–2.60) 17.80
b 73 1.80
c (1.26–2.60) 24.00
b 98 1.63
c (1.20–2.24) 45.00
b 184 1.80
c (1.34–2.36)
Believe overweight 15.00 18 1.60 (0.85–3.00) 18.30 22 1.60 (0.80–3.00) 28.00 33 2.01
c (1.20–3.50) 44.20 53 1.30 (0.79–2.16)
Fear of gaining weight 14.70 26 1.73 (1.00–3.03) 16.40 29 1.43 (0.82–2.51) 26.00 46 1.93
c (1.22–3.10) 42.40 75 1.31 (0.85–2.03)
Amenorrhea 12.20 14 0.94 (0.47–1.90) 12.20 14 0.79 (0.40–1.54) 25.20 29 1.26 (0.77–2.05) 37.40 43 0.73 (0.46–1.20)
85% below ideal weight 13.20 57 1.35 (0.80–2.30) 13.00 55 0.80 (0.50–1.28) 19.00 82 0.67 (0.45–1.00) 39.00 168 0.74 (0.52–1.07)
Note: BN, bulimia nervosa; AN, anorexia nervosa; %, percentage of women positive for speciﬁc eating disorder symptom who also qualify for a substance
disorder diagnosis; N, number of women positive for speciﬁc eating disorder symptom who also qualify for substance disorder diagnosis; OR, odds ratio
from Generalized Estimating Equation (GEE) Modeling; CI, 95% conﬁdence interval for odds ratio.
aAll illicit drug abuse/dependence diagnoses combined into one variable for ease of comparison across eating pathology.
bSigniﬁcant chi-square difference between women positive for symptom and women scoring zero at p\.01.
cGEE analysis signiﬁcant at p\.01.
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difference was shown between those women con-
cerned about their weight and shape and those
who are not in regard to a caffeine disorder (1, N 5
657) 5 12.00, p \.01. Additionally, there was a sig-
niﬁcant chi-square difference between those
women with a history of purging and those without
for any illicit drug use disorder (1, N 5 1707) 5
30.82, p \.01, an alcohol disorder (1, N 5 1711) 5
27.00, p\.01, and regular smoking (1, N 5 1712) 5
27.70, p\.01. Similarly, of those symptoms related
to AN, believing one is overweight when others
believed that the participant was underweight had
the highest prevalence of all the SUDs examined.
However, differences were not signiﬁcant (Table 3).
GEE Analyses
As can be seen from Table 4, very few AN-related
symptoms were signiﬁcantly associated with the
SUDs. However, believing one is overweight when
underweight and fear of gaining weight were signif-
icantly associated with a caffeine use disorder. Hav-
ing this disturbance in body image increased the
chances of a caffeine disorder diagnosis by 2. AN
diagnosis was signiﬁcantly associated with an alco-
hol use disorder (Table 1). Similar to body image
disturbances, there was a twofold increase of an
alcohol use disorder diagnosis in women with AN.
Unlike AN symptomatology, several symptoms
related to BN were signiﬁcantly associated with the
SUDs (Table 4). Binge eating and body image were
signiﬁcantly associated with all the SUDs exam-
ined. Results showed a twofold increase in these
SUDs in women who binge eat or have a negative
body image. Purging behaviors were signiﬁcantly
associated with alcohol and illicit drug disorders as
well as regular smoking. Women who engage in
purging behaviors were two to three times more
likely to have an alcohol or illicit drug disorder or
to smoke regularly. Finally, BN diagnosis was signif-
icantly related to an alcohol or illicit drug use disor-
der increasing the likelihood of having one of these
SUDs by 3( Table 1).
Biometric Twin Analyses
Initial Analyses. Before conducting our bivariate
analyses, we performed univariate analyses to
examine the genetic and environmental inﬂuences
on BNSC and the SUDs. We examined the full ACE
model and compared the ﬁt to the AE, CE, and E
models previously described. The AE model was
the best-ﬁtting model for BNSC. Results suggest
that genetic factors account for 42% (95% CI: 7–
53%) and unique environmental factors account
for 58% (95% CI: 47–70%) of the variance.
For the SUDs, we only examined the full ACE
model to decrease the number of results reported
as this was not a main goal of our analyses, and
most SUDs examined within this report have been
examined in previous VATSPSUD works. All sub-
stances revealed very little shared environmental
effects. Regular smoking showed the largest shared
environmental effects at 5% (95% CI: 0–34%), with
81% (95% CI: 50–91%) genetic, and 14% (95% CI:
10–21%) unique environmental variance. Illicit
drug use disorders had the second largest heritabil-
ity estimated at 68% (95% CI: 32–80%), with the
rest of the variance attributed to unique environ-
TABLE 4. Model-ﬁtting results from bivariate Cholesky models
Model
ra rc re Dv
2;( p) AIC
Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI
Alcohol disorder
and BNSC
ACE model .53 20.02; 1.00 .32 21.00;1.00 2.03 20.24; 0.18 — 21783.44
AE model
a .53 0.30; 0.80 — — 2.03 20.24; 0.18 0 21789.44
Caffeine disorder
and BNSC
ACE model .35 21.00; 1.00 1.00 21.00;1.00 .02 20.15; 0.20 — 21310.34
AE model
a .35 0.03; 0.73 — — .02 20.15; 0.20 0 21316.35
Illicit drug disorder
and BNSC
ACE model .37 20.17; 1.00 0.83 21.00;1.00 .23 20.01; 0.46 — 21942.22
AE model
a .37 0.15; 0.58 — — .23 20.01; 0.46 0 21948.22
Regular smoking
and BNSC
ACE model .25 20.30; 1.00 1.00 21.00;1.00 .05 20.18; 0.28 — 21022.23
AE model
a .35 0.20; 0.51 — — .04 20.20; 0.27 .67; (.88) 21299.75
Note: ra, genetic correlation; rc, shared environmental correlation; re, unique environmental correlation. Dv
2, change in chi-square from full model. p,
p-value associated with change in chi-square; AIC, Akaike’s information criterion; 95% CI, 95% conﬁdence interval; BNSC, bulimia symptom count.
aBest-ﬁtting model according to AIC.
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for an alcohol use disorder and a caffeine disorder
were 53% (95% CI: 7–68%) and 27% (95% CI: 0–
42%), respectively. Again, the rest of the phenotypic
variance was attributed to unique environmental
factors for both an alcohol (47%; 95% CI: 32–64%)
and a caffeine disorder (73%; 95% CI: 58–90%).
Bivariate Twin Analyses. Because at least one BN-
related symptom was signiﬁcantly associated with
the SUDs examined in the GEE analyses, bivariate
twin analyses were conducted with BNSC and all
available SUDs. As shown in Table 5, the strongest
genetic association was between BNSC and an
alcohol use disorder with an estimated genetic cor-
relation of 1.53 (95% CI: 20.02; 11.00). The small-
est genetic association was between BNSC and reg-
ular smoking with an estimated genetic correlation
of 1.25 (95% CI: 20.30; 11.00). However, conﬁ-
dence intervals for the shared environmental corre-
lations range from 21.00 to 11.00 for all analyses
as well as the conﬁdence interval for the genetic
correlation between BNSC and a caffeine disorder.
Conﬁdence intervals that include zero suggest non-
signiﬁcance. Therefore, ra and rc may be nonsigniﬁ-
cant individually. However, because the unique
environmental correlations do not include 61.00,
familial factors are important for the overlap
between BNSC and the SUDs. Our data appear to
be insufﬁcient to determine whether the origin of
familial coaggreation is genetic, shared environ-
mental, or both.
Discussion
The purpose of this study was to examine the asso-
ciation between ED diagnoses, their symptomatol-
ogy, and SUDs. Several important ﬁndings
emerged. First, consistent with the previous litera-
ture,
2 ED diagnoses were signiﬁcantly related to
SUDs. Speciﬁcally, women with AN had a twofold
increased risk of having an alcohol use disorder
and being regular smokers. Women with BN were
two to three times more likely to have an alcohol or
illicit drug use disorder and be regular smokers.
However, in contrast to previous reports, which
generally ﬁnd SUDs to be signiﬁcantly more com-
mon in women with BN compared to AN,
2 our
results showed no signiﬁcant differences between
the prevalence rates of SUDs in women with AN
and BN. Additionally, while results were not statisti-
cally signiﬁcant, a caffeine disorder and regular
smoking were more prevalent in women with AN
compared to BN. These differences could be due to
the fact that our sample is community-based as
opposed to clinical. The nonsigniﬁcant increased
rates of a caffeine disorder and regular smoking in
women with AN also could be due to the common
belief that both these substances increase metabo-
lism. The association between EDs and a caffeine
disorder is also not well studied.
Second, results revealed that, in general, BN
manifests before a SUD. Of women with age of
onset information for both disorders, most
reported binge eating preceded symptoms of a
SUD. This may be occurring because of several
possibilities. First, these women may be beginning
to remit from BN and be substituting substances
for the ED symptoms. Second, the women may be
using substances to dampen bulimic urges or nega-
tive affect. Third, both disorders may be caused by
a common factor, whereas BN symptoms simply
have an earlier onset. In contrast, more women
with AN reported SUD symptoms preceded their
age of lowest weight. The only exception to this
was AN and an alcohol use disorder. It could be
hypothesized that women with AN begin experi-
menting with substances before the onset of AN (or
before a diagnosis can be made) in an effort to lose
weight. Additional possibilities for this pattern
could be the age of onset information used for AN
in this report was the age at lowest weight. Second,
AN diagnosis requires a speciﬁc amount of weight
to be lost before a diagnosis can be made; there-
fore, this ﬁnding may be a reﬂection of our data or
of AN diagnostic criteria.
Third, as hypothesized, several of the ED symp-
toms examined were signiﬁcantly associated with
SUDs. For AN symptomatology, only the variables
reﬂecting body image (fear of gaining weight and
belief overweight when underweight) were signiﬁ-
cantly associated with a SUD. The presence of nega-
tive body image in women who reported having
been under weight previously increased the risk for
a caffeine use disorder by 2. A similar pattern was
revealed for BN-related symptoms. Concern about
weight and shape in women with a history of binge
eating was signiﬁcantly associated with all of the
SUDs examined, again increasing risk by 2. It is
important to note, however, that these body image
symptoms are likely more common in our sample
and show greater variability compared to other ED
symptomatology, which may account for the large
number of signiﬁcant associations revealed. Finally,
binge eating and purging behaviors were signiﬁ-
cantly related to a multitude of SUDs. Binge eating
was associated with all SUDs, whereas purging
behaviors in women with a history of binge eating
showed signiﬁcant associations with all expect a
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hypotheses, based on previous reports, that binge
eating, purging behaviors, and body image would be
associated with an alcohol use disorder and that
purging behaviors would be signiﬁcantly associated
with illicit drug use disorders and regular smoking.
However, we did not ﬁnd a signiﬁcant relation
between AN body image and an alcohol use disorder
identiﬁed by previous research.
9
Forth are the ﬁndings from the twin analyses. To
date, few studies have examined the genetic and
environmental covariance between ED symptomatol-
ogy and SUDs. Moreover, a limited number of inves-
tigations have examined BN using a symptom count.
The univariate BNSC genetic and environmental esti-
mates are similar to our previous examination of
broadly deﬁned BN diagnosis in VATSPSUD.
6
Bivariate analyses indicate a shared etiology
between ED symptomatology and SUDs. Although
our data may not have been sufﬁcient to differentiate
between genetic and shared environmental effects
on comorbidity, our results do indicate that familial
factors are important for the overlap between these
two disorders, which is consistent with previous
research.
6,17 Because no re conﬁdence intervals
included 1.00, we know that individual-speciﬁc envi-
ronmental factors are not sufﬁcient to account for
the overlap. Estimated genetic correlations from the
ACE models ranged from 1.25 to 1.53, with the high-
est correlation between BNSC and an alcohol use dis-
order. This contrasts a previous VATSPSUD report
investigating genetic covariance between alcoholism
and BN diagnosis (along with four other disorders).
14
Kendler and colleagues
14 n o t e dt h a tm o s to ft h e
genetic factors responsible for alcoholism were disor-
der speciﬁc and unrelated to the factors that inﬂu-
ence BN (as well as mood and anxiety disorders). Dif-
ferences could have arisen, because the previous
report used a broad deﬁnition of alcoholism, a differ-
ing deﬁnition of BN, a best-ﬁt model, and a multivar-
iate common factor model.
Results also indicate that the relationship
between BNSC and SUDs may not be substance
speciﬁc as a majority of the SUDs examined
showed common familial inﬂuences with BNSC.
This result makes sense in the light of substance
use literature that shows genetic inﬂuences on
both substance use and SUDs is not substance spe-
ciﬁc, but produces a general vulnerability to use or
misuse.
36–38 This common familial susceptibility to
BN-related behaviors and substance misuse may
simply place an individual at risk for both, whereas
additional speciﬁc factors determine the exact type
of substance used (e.g., availability). This may also
provide limited evidence for BN as an addictive dis-
order. It could be that there is a general vulnerabil-
ity to BN and substance misuse and that additional
speciﬁc factors (e.g., personality) determine which
behaviors arise.
Finally, this is one of the ﬁrst studies to examine
the comorbidity of ED symptomatology and a caf-
feine disorder. Although neither AN nor BN diag-
noses were signiﬁcantly associated with a caffeine
disorder in GEE analyses, several ED symptoms
were. Body image related to both AN and BN as
well as binge eating were signiﬁcantly related to a
caffeine disorder, corroborating research showing
a correlation between binge frequency and caf-
feine use.
10
There are limitations to this study that warrant
discussion. First, and perhaps most noteworthy, is
the way our ED symptom variables were created,
speciﬁcally the use of entry questions. Although
the use of entry questions is common practice in
large scale, interview-based studies to ease the bur-
den of participants; this can be problematic when
examining symptomatology. Although the entry
questions are part of the diagnostic criteria for AN
or BN, we still are not able to obtain ‘‘true’’ symp-
tom counts as it is possible to have participants
whom purge but not binge eat, for example.
Second is our insufﬁcient power to differentiate
between genetic and shared environmental effects.
Although our sample size is large in terms of both
general population and twin samples, we still did
not have the power to reject the AE model if the CE
model was the true, best-ﬁtting model. However,
for a small effect size, an exceptionally and possibly
unreasonably large sample of twin pairs would
be needed. Despite the inability to differentiate
between common genetic and shared environmen-
tal effects, results still provide clear evidence for
the importance of familial factors impacting the
comorbity between BNSC and SUDs. Third is the
retrospective nature of the data. This method can
have an impact on the reliability and validity of the
twins’ reports. However, BN diagnosis within our
Wave 3 sample has been shown to be reliable.
28
A fourth potential limitation is merging substance
abuse and dependence into a combined variable.
Importantly, however, examinations within our own
data have never produced results, suggesting dis-
tinct genetic risk factors for alcohol abuse versus de-
pendence
25,39 and other substances.
40 Therefore,
collapsing categories would not have a signiﬁcant
impact on results. Other limitations include the fact
that women who were born between 1934 and 1968
were ascertained for the VATSPSUD, so there could
be age or cohort effects on results and the use of
broader deﬁnitions of AN and BN.
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several strengths including the use of ED diagno-
ses, symptoms, and a BN symptom count variable.
As discussed, research is emphasizing the impor-
tance of examining ED symptoms as opposed to
diagnoses, which might only represent occasion-
ally co-occurring etiological diverse symptoms.
18
We attempted to address this issue by including
symptoms rather than relying solely on diagnoses
in our investigations. Second, we thoroughly
assessed the temporal relationship of AN, BN, and
SUDs. A limited amount of studies have examined
this in both AN and BN. Third, we used a popula-
tion-based sample, increasing the generaliability
of our results.
Current ﬁndings have important implications for
future research as well as clinical work. Further
investigations regarding genetic and environmental
inﬂuences on associations among speciﬁc ED
symptoms and SUDs are important for treatment
and prevention efforts. Moreover, women present-
ing with either an ED or a SUD should be assessed
for symptoms of the other disorder. Importantly,
women with subthreshold levels of EDs may be
vulnerable to developing a SUD, as speciﬁc symp-
toms as well as overall diagnosis, were related to
substance use. EDs continue to be among the most
difﬁcult psychiatric disorders to treat. Continued
elucidation of predisposing and maintaining fac-
tors, including comorbid relationships, is essential
in addressing these pernicious behaviors.
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